By Ben Glickman
Shares of Akumin rose Friday after the company said it had agreed to be taken private by private-equity firm Stonepeak.
The stock was up 41% to 21 cents in after-hours trading, following a 0.4% rise at Friday’s close. Shares are down 80% this year.
The Plantation, Fla.-based outpatient radiology and oncology company said Stonepeak’s note of $470 million would be cancelled and converted to Akumin stock. Stonepeak will also invest $130 million in the company.
Shareholders will get $25 million in cash and contingent value rights for Akumin shares.
The company expects the prepackaged chapter 11 case to be approved by courts in 45 days.
Write to Ben Glickman at ben.glickman@wsj.com
Read the full article here
